Analysis of data from The Cancer Genome Atlas and Genotype‐Tissue Expression databases revealed that KIR2DL1, KIR2DL3 and KIR2DL4 expression were significantly upregulated in AML and associated with decreased overall survival (OS). This evidence concerns the gene KIR2DL4 and cancer.